EP2672957
Ný samsetning til meðferðar við slímseigjusjúkdóm
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.2.2012EP published:
2.11.2016EP application number:
12704027.7
EP translation filed:
5.1.2017Grant published:
15.1.2017EPO information:
European Patent Register
Max expiry date:
2.2.2032Expiry date:
2.2.2027Next due date:
28.2.2027
Title:
NOVEL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS
Timeline
Owner
Name:
SciPharm SàRLAddress:
26-28, rue Edward Steichen, 2540, Luxembourg, LU
Inventor
Name:
FREISSMUTH, MichaelAddress:
Wien, AT
Name:
GLOECKEL, ChristinaAddress:
Wien, AT
Name:
KOENIG, XaverAddress:
Wien, AT
Name:
KEUERLEBER, SimonAddress:
Wien, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
11153541Date:
7.2.2011Country:
EP
Classification
Categories:
A61K 31/437, A61K 31/44, A61K 45/06, A61K 31/5575, A61K 31/5578, A61K 31/5585, A61P 11/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.2.2017
Expires: 2.2.2018
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 19.1.2018
Expires: 2.2.2019
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 22.1.2019
Expires: 2.2.2020
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 21.1.2020
Expires: 2.2.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 10.2.2021
Expires: 2.2.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 10.2.2022
Expires: 2.2.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 10.2.2023
Expires: 2.2.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 10.2.2023
Expires: 2.2.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 12.2.2024
Expires: 2.2.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 14
Paid: 11.2.2025
Expires: 2.2.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 15
Paid: 16.2.2026
Expires: 2.2.2027
Payer: G.H. Sigurgeirsson ehf.